| Serial Number | 97042228 |
| Word Mark | MORPHOSYS |
| Filing Date | Thursday, September 23, 2021 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, June 6, 2023 |
| Registration Number | 7071326 |
| Registration Date | Tuesday, June 6, 2023 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, March 21, 2023 |
| Goods and Services | pharmaceutical preparations for the treatment of diseases that involve dysregulation of epigenetic pathways; pharmaceutical preparations for epigenetic modulators as therapeutics; pharmaceuticals comprising small molecules for the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; small molecule compounds for use as drug delivery agents in pharmaceuticals; small molecule compounds being pharmaceuticals for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis in humans; small molecule pharmaceuticals for the treatment of diseases and conditions, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Pharmaceuticals and pharmaceutical preparations for human use for the treatment and prevention of diseases and disorders, namely, metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; antibodies sold as a component ingredient of pharmaceuticals for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; diagnostic preparations for medical purposes; biological substances for human medical diagnostics and analysis for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; Clinical medical reagents; Biological preparations for medical purposes, namely, for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis; pharmaceutical and veterinary preparations, agents and substances for the treatment of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis |
| Goods and Services | reagents for scientific and medical research for use in the research and production of small molecule pharmaceuticals; active pharmaceutical ingredients, namely, antibodies, proteins and small molecules for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; antibodies for use in the manufacture of active ingredients of pharmaceuticals and vaccines |
| Goods and Services | Pharmaceutical research and development of pharmaceutical preparations, medicines and vaccines; providing medical and scientific research information; Scientific research in the nature of conducting clinical trials for others; scientific and technological services, namely, scientific research, analysis, and testing services in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology; research and design services, namely, research and development in the field of antibodies and clinical research in connection with the treatment and prevention of metabolic disorders, infectious diseases, cancer, inflammatory diseases, Alzheimer's, sepsis, and restenosis |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 10, 2023 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, February 10, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, February 1, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MorphoSys AG |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Party Name | MorphoSys AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Party Name | MorphoSys AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Planegg D-82152 DE |
| Event Date | Event Description |
| Tuesday, June 6, 2023 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
| Tuesday, June 6, 2023 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, March 21, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 21, 2023 | PUBLISHED FOR OPPOSITION |
| Wednesday, March 1, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Monday, February 13, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Friday, February 10, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Friday, February 10, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Friday, February 10, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Friday, February 10, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, February 1, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Wednesday, February 1, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 1, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Wednesday, February 1, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, January 10, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, January 10, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, January 9, 2023 | ASSIGNED TO LIE |
| Friday, November 11, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, June 27, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 27, 2022 | NON-FINAL ACTION E-MAILED |
| Monday, June 27, 2022 | NON-FINAL ACTION WRITTEN |
| Friday, June 24, 2022 | ASSIGNED TO EXAMINER |
| Monday, October 25, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, September 27, 2021 | NEW APPLICATION ENTERED |